Encephalitis as a neurological complication of COVID‐19: A systematic review and meta‐analysis of incidence, outcomes, and predictors
Background and purpose Although COVID‐19 predominantly affects the respiratory system, recent studies have reported the occurrence of neurological disorders such as stroke in relation to COVID‐19 infection. Encephalitis is an inflammatory condition of the brain that has been described as a severe ne...
Uloženo v:
| Vydáno v: | European journal of neurology Ročník 28; číslo 10; s. 3491 - 3502 |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
England
John Wiley & Sons, Inc
01.10.2021
John Wiley and Sons Inc |
| Témata: | |
| ISSN: | 1351-5101, 1468-1331, 1468-1331 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Background and purpose
Although COVID‐19 predominantly affects the respiratory system, recent studies have reported the occurrence of neurological disorders such as stroke in relation to COVID‐19 infection. Encephalitis is an inflammatory condition of the brain that has been described as a severe neurological complication of COVID‐19. Despite a growing number of reported cases, encephalitis related to COVID‐19 infection has not been adequately characterised. To address this gap, this systematic review and meta‐analysis aims to describe the incidence, clinical course, and outcomes of patients who suffer from encephalitis as a complication of COVID‐19.
Methods
All studies published between 1 November 2019 and 24 October 2020 that reported on patients who developed encephalitis as a complication of COVID‐19 were included. Only cases with radiological and/or biochemical evidence of encephalitis were included.
Results
In this study, 610 studies were screened and 23 studies reporting findings from 129,008 patients, including 138 with encephalitis, were included. The average time from diagnosis of COVID‐19 to onset of encephalitis was 14.5 days (range = 10.8–18.2 days). The average incidence of encephalitis as a complication of COVID‐19 was 0.215% (95% confidence interval [CI] = 0.056%–0.441%). The average mortality rate of encephalitis in COVID‐19 patients was 13.4% (95% CI = 3.8%–25.9%). These patients also had deranged clinical parameters, including raised serum inflammatory markers and cerebrospinal fluid pleocytosis.
Conclusions
Although encephalitis is an uncommon complication of COVID‐19, when present, it results in significant morbidity and mortality. Severely ill COVID‐19 patients are at higher risk of suffering from encephalitis as a complication of the infection. |
|---|---|
| AbstractList | Background and purposeAlthough COVID‐19 predominantly affects the respiratory system, recent studies have reported the occurrence of neurological disorders such as stroke in relation to COVID‐19 infection. Encephalitis is an inflammatory condition of the brain that has been described as a severe neurological complication of COVID‐19. Despite a growing number of reported cases, encephalitis related to COVID‐19 infection has not been adequately characterised. To address this gap, this systematic review and meta‐analysis aims to describe the incidence, clinical course, and outcomes of patients who suffer from encephalitis as a complication of COVID‐19.MethodsAll studies published between 1 November 2019 and 24 October 2020 that reported on patients who developed encephalitis as a complication of COVID‐19 were included. Only cases with radiological and/or biochemical evidence of encephalitis were included.ResultsIn this study, 610 studies were screened and 23 studies reporting findings from 129,008 patients, including 138 with encephalitis, were included. The average time from diagnosis of COVID‐19 to onset of encephalitis was 14.5 days (range = 10.8–18.2 days). The average incidence of encephalitis as a complication of COVID‐19 was 0.215% (95% confidence interval [CI] = 0.056%–0.441%). The average mortality rate of encephalitis in COVID‐19 patients was 13.4% (95% CI = 3.8%–25.9%). These patients also had deranged clinical parameters, including raised serum inflammatory markers and cerebrospinal fluid pleocytosis.ConclusionsAlthough encephalitis is an uncommon complication of COVID‐19, when present, it results in significant morbidity and mortality. Severely ill COVID‐19 patients are at higher risk of suffering from encephalitis as a complication of the infection. Although COVID-19 predominantly affects the respiratory system, recent studies have reported the occurrence of neurological disorders such as stroke in relation to COVID-19 infection. Encephalitis is an inflammatory condition of the brain that has been described as a severe neurological complication of COVID-19. Despite a growing number of reported cases, encephalitis related to COVID-19 infection has not been adequately characterised. To address this gap, this systematic review and meta-analysis aims to describe the incidence, clinical course, and outcomes of patients who suffer from encephalitis as a complication of COVID-19.BACKGROUND AND PURPOSEAlthough COVID-19 predominantly affects the respiratory system, recent studies have reported the occurrence of neurological disorders such as stroke in relation to COVID-19 infection. Encephalitis is an inflammatory condition of the brain that has been described as a severe neurological complication of COVID-19. Despite a growing number of reported cases, encephalitis related to COVID-19 infection has not been adequately characterised. To address this gap, this systematic review and meta-analysis aims to describe the incidence, clinical course, and outcomes of patients who suffer from encephalitis as a complication of COVID-19.All studies published between 1 November 2019 and 24 October 2020 that reported on patients who developed encephalitis as a complication of COVID-19 were included. Only cases with radiological and/or biochemical evidence of encephalitis were included.METHODSAll studies published between 1 November 2019 and 24 October 2020 that reported on patients who developed encephalitis as a complication of COVID-19 were included. Only cases with radiological and/or biochemical evidence of encephalitis were included.In this study, 610 studies were screened and 23 studies reporting findings from 129,008 patients, including 138 with encephalitis, were included. The average time from diagnosis of COVID-19 to onset of encephalitis was 14.5 days (range = 10.8-18.2 days). The average incidence of encephalitis as a complication of COVID-19 was 0.215% (95% confidence interval [CI] = 0.056%-0.441%). The average mortality rate of encephalitis in COVID-19 patients was 13.4% (95% CI = 3.8%-25.9%). These patients also had deranged clinical parameters, including raised serum inflammatory markers and cerebrospinal fluid pleocytosis.RESULTSIn this study, 610 studies were screened and 23 studies reporting findings from 129,008 patients, including 138 with encephalitis, were included. The average time from diagnosis of COVID-19 to onset of encephalitis was 14.5 days (range = 10.8-18.2 days). The average incidence of encephalitis as a complication of COVID-19 was 0.215% (95% confidence interval [CI] = 0.056%-0.441%). The average mortality rate of encephalitis in COVID-19 patients was 13.4% (95% CI = 3.8%-25.9%). These patients also had deranged clinical parameters, including raised serum inflammatory markers and cerebrospinal fluid pleocytosis.Although encephalitis is an uncommon complication of COVID-19, when present, it results in significant morbidity and mortality. Severely ill COVID-19 patients are at higher risk of suffering from encephalitis as a complication of the infection.CONCLUSIONSAlthough encephalitis is an uncommon complication of COVID-19, when present, it results in significant morbidity and mortality. Severely ill COVID-19 patients are at higher risk of suffering from encephalitis as a complication of the infection. Background and purpose Although COVID‐19 predominantly affects the respiratory system, recent studies have reported the occurrence of neurological disorders such as stroke in relation to COVID‐19 infection. Encephalitis is an inflammatory condition of the brain that has been described as a severe neurological complication of COVID‐19. Despite a growing number of reported cases, encephalitis related to COVID‐19 infection has not been adequately characterised. To address this gap, this systematic review and meta‐analysis aims to describe the incidence, clinical course, and outcomes of patients who suffer from encephalitis as a complication of COVID‐19. Methods All studies published between 1 November 2019 and 24 October 2020 that reported on patients who developed encephalitis as a complication of COVID‐19 were included. Only cases with radiological and/or biochemical evidence of encephalitis were included. Results In this study, 610 studies were screened and 23 studies reporting findings from 129,008 patients, including 138 with encephalitis, were included. The average time from diagnosis of COVID‐19 to onset of encephalitis was 14.5 days (range = 10.8–18.2 days). The average incidence of encephalitis as a complication of COVID‐19 was 0.215% (95% confidence interval [CI] = 0.056%–0.441%). The average mortality rate of encephalitis in COVID‐19 patients was 13.4% (95% CI = 3.8%–25.9%). These patients also had deranged clinical parameters, including raised serum inflammatory markers and cerebrospinal fluid pleocytosis. Conclusions Although encephalitis is an uncommon complication of COVID‐19, when present, it results in significant morbidity and mortality. Severely ill COVID‐19 patients are at higher risk of suffering from encephalitis as a complication of the infection. Although COVID-19 predominantly affects the respiratory system, recent studies have reported the occurrence of neurological disorders such as stroke in relation to COVID-19 infection. Encephalitis is an inflammatory condition of the brain that has been described as a severe neurological complication of COVID-19. Despite a growing number of reported cases, encephalitis related to COVID-19 infection has not been adequately characterised. To address this gap, this systematic review and meta-analysis aims to describe the incidence, clinical course, and outcomes of patients who suffer from encephalitis as a complication of COVID-19. All studies published between 1 November 2019 and 24 October 2020 that reported on patients who developed encephalitis as a complication of COVID-19 were included. Only cases with radiological and/or biochemical evidence of encephalitis were included. In this study, 610 studies were screened and 23 studies reporting findings from 129,008 patients, including 138 with encephalitis, were included. The average time from diagnosis of COVID-19 to onset of encephalitis was 14.5 days (range = 10.8-18.2 days). The average incidence of encephalitis as a complication of COVID-19 was 0.215% (95% confidence interval [CI] = 0.056%-0.441%). The average mortality rate of encephalitis in COVID-19 patients was 13.4% (95% CI = 3.8%-25.9%). These patients also had deranged clinical parameters, including raised serum inflammatory markers and cerebrospinal fluid pleocytosis. Although encephalitis is an uncommon complication of COVID-19, when present, it results in significant morbidity and mortality. Severely ill COVID-19 patients are at higher risk of suffering from encephalitis as a complication of the infection. |
| Author | Siow, Isabel Saffari, Seyed Ehsan Ng, Adeline Lee, Keng Siang Zhang, John J. Y. |
| AuthorAffiliation | 5 Neuroscience and Behavioural Disorders Duke‐NUS Singapore Singapore 3 Health Services & Systems Research Duke‐NUS Medical School Singapore Singapore 1 Yong Loo Lin School of Medicine National University of Singapore Singapore Singapore 2 Bristol Medical School Faculty of Health Sciences University of Bristol Bristol UK 4 Department of Neurology National Neuroscience Institute Singapore Singapore |
| AuthorAffiliation_xml | – name: 1 Yong Loo Lin School of Medicine National University of Singapore Singapore Singapore – name: 2 Bristol Medical School Faculty of Health Sciences University of Bristol Bristol UK – name: 3 Health Services & Systems Research Duke‐NUS Medical School Singapore Singapore – name: 5 Neuroscience and Behavioural Disorders Duke‐NUS Singapore Singapore – name: 4 Department of Neurology National Neuroscience Institute Singapore Singapore |
| Author_xml | – sequence: 1 givenname: Isabel orcidid: 0000-0001-5989-1424 surname: Siow fullname: Siow, Isabel email: isabel.siow@yahoo.com.sg organization: National University of Singapore – sequence: 2 givenname: Keng Siang orcidid: 0000-0003-2308-0579 surname: Lee fullname: Lee, Keng Siang organization: University of Bristol – sequence: 3 givenname: John J. Y. surname: Zhang fullname: Zhang, John J. Y. organization: National University of Singapore – sequence: 4 givenname: Seyed Ehsan surname: Saffari fullname: Saffari, Seyed Ehsan organization: Duke‐NUS Medical School – sequence: 5 givenname: Adeline surname: Ng fullname: Ng, Adeline email: adeline.ng.s.l@singhealth.com.sg organization: Duke‐NUS |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33982853$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1kktrVTEQx4NU7EMXfgEJuFHoafM4TxdCuV61UOxG3YacnDltSk5ym5zTcnfddudn9JM491HRoiGQgfn9_xlmZp_s-OCBkJecHXE8x-DhiOcNl0_IHs_LOuNS8h2MZcGzgjO-S_ZTumKMiUqwZ2RXyqYWdSH3yP3cG1hcamdHm6jGSz1MMbhwYY121IRh4TAabfA09HR2_v30w8-7H7x5R09oWqYRBkwaGuHGwi3VvqMDjBoR7bVbJnRFmfXGdoBfHdIwjWgK6XDNLiJ01owhpufkaa9dghfb94B8-zj_OvucnZ1_Op2dnGWmkJXM6kbKQnYtB-jKWrQtazjkZWWgBSHKsmad6fq613nT6YZXjGnNwORt3-qqlkYekPcb38XUDtAZ8GPUTi2iHXRcqqCt-jvj7aW6CDeqFquuMTR4szWI4XqCNKrBJgPOaQ9hSkoUopSsKqsC0deP0KswRezLiqoQZEJwpF79WdHvUh6mhMDxBjAxpBShV8aO65FggdYpztRqDxTugVrvASrePlI8mP6L3brfWgfL_4Nq_mW-UfwCHw7FmQ |
| CitedBy_id | crossref_primary_10_1186_s12883_021_02449_5 crossref_primary_10_1007_s12311_022_01366_8 crossref_primary_10_3897_folmed_66_e124015 crossref_primary_10_3389_fnins_2023_1004957 crossref_primary_10_1080_14737175_2023_2239500 crossref_primary_10_1016_j_jneuroim_2025_578590 crossref_primary_10_1084_jem_20231725 crossref_primary_10_17116_jnevro2023123072103 crossref_primary_10_7759_cureus_29838 crossref_primary_10_1097_WCO_0000000000001158 crossref_primary_10_3390_nu16213586 crossref_primary_10_1016_j_jmii_2023_08_010 crossref_primary_10_1007_s12015_022_10409_w crossref_primary_10_1111_ane_13621 crossref_primary_10_3389_fnins_2023_1232480 crossref_primary_10_1007_s00415_023_11914_9 crossref_primary_10_1177_19418744231202317 crossref_primary_10_1186_s12887_025_05436_8 crossref_primary_10_1007_s00415_023_11691_5 crossref_primary_10_1093_qjmed_hcac211 crossref_primary_10_1128_jcm_00731_23 crossref_primary_10_1136_bmj_2022_073923 crossref_primary_10_7759_cureus_79517 crossref_primary_10_3390_cells11203212 crossref_primary_10_1002_jcla_24426 crossref_primary_10_1016_j_radcr_2023_11_044 crossref_primary_10_3390_vaccines11020208 crossref_primary_10_1002_mdc3_13461 crossref_primary_10_1186_s12915_025_02293_w crossref_primary_10_1186_s12883_022_02782_3 crossref_primary_10_1002_pnp_723 crossref_primary_10_1007_s00705_023_05801_x crossref_primary_10_1016_j_pedneo_2024_09_009 crossref_primary_10_1111_ene_16096 crossref_primary_10_3389_fneur_2023_1207883 crossref_primary_10_1007_s10072_022_06044_5 crossref_primary_10_3389_fmicb_2023_1320856 crossref_primary_10_1177_11795735221147218 crossref_primary_10_1186_s40942_024_00552_6 crossref_primary_10_4103_aian_aian_204_22 crossref_primary_10_1002_rmv_2430 crossref_primary_10_1136_postgradmedj_2022_141724 crossref_primary_10_1111_ncn3_12677 crossref_primary_10_3390_biom13111585 crossref_primary_10_3390_gidisord5030028 crossref_primary_10_3390_diagnostics12040924 crossref_primary_10_1016_j_idc_2025_02_002 crossref_primary_10_1186_s13256_022_03539_9 crossref_primary_10_1212_CON_0000000000001272 crossref_primary_10_1016_j_brainresbull_2025_111513 crossref_primary_10_1007_s00354_023_00222_5 crossref_primary_10_7759_cureus_38194 crossref_primary_10_1177_23247096231208771 crossref_primary_10_1016_j_seizure_2022_07_005 crossref_primary_10_17116_jnevro202412402120 crossref_primary_10_1002_jmv_28490 crossref_primary_10_1186_s12883_021_02517_w crossref_primary_10_7759_cureus_51829 crossref_primary_10_1016_j_nerep_2022_100162 crossref_primary_10_1038_s41598_025_10750_3 crossref_primary_10_3390_vaccines11020425 crossref_primary_10_1007_s13760_022_01898_0 crossref_primary_10_7759_cureus_37373 crossref_primary_10_17116_jnevro202512507212 crossref_primary_10_3390_cells11091458 crossref_primary_10_1016_j_idcr_2025_e02220 crossref_primary_10_1128_cmr_00131_24 crossref_primary_10_1080_14737175_2022_2038136 crossref_primary_10_1111_jebm_12510 crossref_primary_10_3390_brainsci12070902 crossref_primary_10_1016_S2213_2600_23_00238_2 crossref_primary_10_3390_neurolint15010005 crossref_primary_10_1016_j_acra_2025_02_022 crossref_primary_10_1080_01616412_2024_2349440 crossref_primary_10_1136_bcr_2022_251922 crossref_primary_10_3390_brainsci12111531 crossref_primary_10_3390_v16081183 crossref_primary_10_1212_NXI_0000000000200112 crossref_primary_10_7861_clinmed_Let_22_5_2 crossref_primary_10_1186_s13256_024_05006_z crossref_primary_10_7759_cureus_62056 crossref_primary_10_1136_postgradmedj_2022_141812 crossref_primary_10_1016_j_jmii_2023_10_005 crossref_primary_10_1007_s00117_021_00907_2 crossref_primary_10_1016_j_bbi_2024_11_007 crossref_primary_10_1016_j_neurol_2021_12_002 crossref_primary_10_1038_s41598_024_80833_0 crossref_primary_10_3389_fmed_2021_745789 crossref_primary_10_1002_jcb_30683 crossref_primary_10_1007_s13365_024_01202_1 crossref_primary_10_1097_QCO_0000000000000922 crossref_primary_10_1002_ccr3_6587 crossref_primary_10_1053_j_sult_2024_03_003 crossref_primary_10_1007_s13311_022_01267_y crossref_primary_10_7759_cureus_51071 crossref_primary_10_31083_j_jin2103077 crossref_primary_10_5694_mja2_52063 crossref_primary_10_3390_biomedicines12061147 crossref_primary_10_1002_pnp_779 crossref_primary_10_1007_s10072_024_07587_5 crossref_primary_10_1186_s41747_025_00598_7 crossref_primary_10_3390_biomedicines10040774 crossref_primary_10_1093_qjmed_hcac272 crossref_primary_10_1159_000530536 crossref_primary_10_3389_fimmu_2023_1240089 crossref_primary_10_3390_antibiotics13040367 |
| Cites_doi | 10.1002/jmv.26309 10.3389/fneur.2020.00805 10.1016/j.crad.2016.03.015 10.1016/j.nrleng.2020.07.012 10.1017/S0950268820001910 10.3389/fmed.2019.00118 10.1002/jmv.26207 10.1186/2049-3258-72-39 10.1136/jnnp-2020-323929 10.1016/j.bbih.2020.100136 10.1002/9781119536604 10.1111/jebm.12141 10.1016/S2215-0366(20)30287-X 10.1016/j.ensci.2020.100275 10.1016/j.jstrokecerebrovasdis.2020.105549 10.1212/WNL.0000000000010112 10.1016/j.ajem.2020.08.005 10.1371/journal.pmed.1000097 10.1016/j.bbi.2020.05.022 10.1016/j.jns.2020.117118 10.1007/s00415-020-10108-x 10.1016/j.jocn.2020.04.062 10.1038/s41582-020-0398-3 10.12659/AJCR.925641 10.1186/s41983-020-00244-6 10.1016/j.jinf.2009.02.011 10.1212/WNL.0000000000009937 10.1002/acn3.51210 10.3201/eid2609.202122 10.1093/brain/awaa240 10.1186/s13054-020-03200-1 10.21203/rs.3.rs-65579/v1 10.1136/bcr-2020-238668 10.3390/ijms21155475 10.1111/ene.14444 10.1016/S1473-3099(20)30195-X 10.1136/bcr-2020-239597 10.1177/0885066619892826 10.3174/ajnr.A6715 10.1016/j.bbih.2020.100094 |
| ContentType | Journal Article |
| Copyright | 2021 European Academy of Neurology 2021 European Academy of Neurology. Copyright © 2021 European Academy of Neurology |
| Copyright_xml | – notice: 2021 European Academy of Neurology – notice: 2021 European Academy of Neurology. – notice: Copyright © 2021 European Academy of Neurology |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7TK 7U7 C1K K9. 7X8 5PM |
| DOI | 10.1111/ene.14913 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Neurosciences Abstracts Toxicology Abstracts Environmental Sciences and Pollution Management ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) Toxicology Abstracts Neurosciences Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
| DatabaseTitleList | ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| DocumentTitleAlternate | Encephalitis and COVID‐19 |
| EISSN | 1468-1331 |
| EndPage | 3502 |
| ExternalDocumentID | PMC8239820 33982853 10_1111_ene_14913 ENE14913 |
| Genre | reviewArticle Meta-Analysis Systematic Review Journal Article |
| GroupedDBID | --- .3N .GA .Y3 05W 0R~ 10A 169 1OB 1OC 24P 29G 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5VS 66C 702 7PT 7X7 8-0 8-1 8-3 8-4 8-5 8FI 8FJ 8UM 930 A01 A03 AAESR AAEVG AAHHS AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABIVO ABJNI ABPVW ABUWG ABXGK ACAHQ ACBWZ ACCFJ ACCMX ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADPDF ADXAS ADZMN ADZOD AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFGKR AFKRA AFPWT AFRAH AFWVQ AFZJQ AHMBA AIACR AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BENPR BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG CCPQU COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBS EJD EMOBN ESX EX3 F00 F5P FEDTE FUBAC FYBCS FYUFA G-S G.N GODZA H.X HF~ HMCUK HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD OVEED P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 R.K RIG RIWAO RJQFR ROL RPM RX1 SAMSI SUPJJ TEORI UB1 UKHRP W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WVDHM WXI WXSBR XG1 YFH ZZTAW ~IA ~WT AAMMB AAYXX AEFGJ AGQPQ AGXDD AIDQK AIDYY AIQQE CITATION GROUPED_DOAJ O8X PHGZM WIN CGR CUY CVF ECM EIF NPM 7TK 7U7 C1K K9. 7X8 5PM |
| ID | FETCH-LOGICAL-c5373-893353db1eed682bb091e467cebe226680dcdf8fa49da91700aa0ec4bfba783c3 |
| IEDL.DBID | WIN |
| ISICitedReferencesCount | 119 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000656820000001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1351-5101 1468-1331 |
| IngestDate | Tue Nov 04 01:36:53 EST 2025 Thu Sep 04 18:09:48 EDT 2025 Sat Nov 29 14:45:03 EST 2025 Mon Jul 21 06:02:09 EDT 2025 Sat Nov 29 05:12:51 EST 2025 Tue Nov 18 21:58:53 EST 2025 Wed Jan 22 16:28:59 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 10 |
| Keywords | COVID-19 coronavirus complication encephalitis |
| Language | English |
| License | 2021 European Academy of Neurology. This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c5373-893353db1eed682bb091e467cebe226680dcdf8fa49da91700aa0ec4bfba783c3 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Feature-3 ObjectType-Evidence Based Healthcare-1 ObjectType-Article-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 ObjectType-Undefined-4 |
| ORCID | 0000-0001-5989-1424 0000-0003-2308-0579 |
| OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC8239820 |
| PMID | 33982853 |
| PQID | 2572520221 |
| PQPubID | 1066358 |
| PageCount | 12 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_8239820 proquest_miscellaneous_2526307675 proquest_journals_2572520221 pubmed_primary_33982853 crossref_citationtrail_10_1111_ene_14913 crossref_primary_10_1111_ene_14913 wiley_primary_10_1111_ene_14913_ENE14913 |
| PublicationCentury | 2000 |
| PublicationDate | October 2021 |
| PublicationDateYYYYMMDD | 2021-10-01 |
| PublicationDate_xml | – month: 10 year: 2021 text: October 2021 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: Oxford – name: Hoboken |
| PublicationTitle | European journal of neurology |
| PublicationTitleAlternate | Eur J Neurol |
| PublicationYear | 2021 |
| Publisher | John Wiley & Sons, Inc John Wiley and Sons Inc |
| Publisher_xml | – name: John Wiley & Sons, Inc – name: John Wiley and Sons Inc |
| References | 2019; 6 2020; 20 2020; 41 2021; 268 2020; 143 2019; 36 2020; 148 2020; 16 2020; 13 2020; 35 2020; 12 2016; 71 2020; 56 2020; 11 2020; 76 2021; 93 2021; 30 2015; 8 2020; 8 2020; 7 2009; 58 2020; 5 2020; 95 2020 2020; 92 2020; 27 2019 2020; 24 2020; 45 2009; 6 2020; 87 2013 2020; 21 2014; 72 2020; 418 e_1_2_12_4_1 e_1_2_12_6_1 e_1_2_12_19_1 e_1_2_12_2_1 e_1_2_12_17_1 e_1_2_12_38_1 Zhang T (e_1_2_12_43_1) 2020 e_1_2_12_20_1 e_1_2_12_41_1 e_1_2_12_22_1 Haider A (e_1_2_12_46_1) 2020; 12 e_1_2_12_45_1 e_1_2_12_26_1 e_1_2_12_47_1 e_1_2_12_28_1 e_1_2_12_49_1 e_1_2_12_31_1 Mondal R (e_1_2_12_12_1) 2020; 27 e_1_2_12_37_1 e_1_2_12_14_1 e_1_2_12_8_1 e_1_2_12_10_1 e_1_2_12_50_1 e_1_2_12_3_1 e_1_2_12_5_1 e_1_2_12_18_1 e_1_2_12_16_1 Rifino N (e_1_2_12_35_1) 2020 e_1_2_12_39_1 Team RC. R (e_1_2_12_21_1) 2013 e_1_2_12_42_1 e_1_2_12_44_1 e_1_2_12_23_1 e_1_2_12_25_1 e_1_2_12_48_1 e_1_2_12_40_1 e_1_2_12_27_1 e_1_2_12_29_1 Iltaf S (e_1_2_12_24_1) 2020; 12 e_1_2_12_30_1 e_1_2_12_32_1 e_1_2_12_34_1 e_1_2_12_36_1 e_1_2_12_15_1 e_1_2_12_13_1 e_1_2_12_11_1 e_1_2_12_7_1 Pilotto A (e_1_2_12_33_1) 2020 e_1_2_12_9_1 |
| References_xml | – volume: 5 start-page: 100094 year: 2020 article-title: Neurological involvement in SARS‐CoV‐2 infection: a clinical systematic review publication-title: Brain Behav Immun Health – year: 2020 article-title: COVID‐19‐associated acute disseminated encephalomyelitis: a case report publication-title: MedRxiv – volume: 13 issue: 8 year: 2020 article-title: COVID‐19–associated acute transverse myelitis: a rare entity publication-title: BMJ Case Reports CP – volume: 56 start-page: 1 issue: 1 year: 2020 end-page: 7 article-title: A brief review of the neurological manifestations of the coronavirus disease publication-title: Egypt J Neurol Psychiatr Neurosurg – volume: 11: start-page: 805 year: 2020 article-title: Inpatient neurology consultations during the onset of the SARS‐CoV‐2 New York City pandemic: a single center case series publication-title: Front Neurol – volume: 7 start-page: 2221 issue: 11 year: 2020 end-page: 2230 article-title: Frequent neurologic manifestations and encephalopathy‐associated morbidity in Covid‐19 patients publication-title: Ann Clin Transl Neurol – volume: 12 issue: 10 year: 2020 article-title: COVID‐19 and the brain: acute encephalitis as a clinical manifestation publication-title: Cureus – volume: 95 start-page: e1868 issue: 13 year: 2020 end-page: e1882 article-title: Neurologic and neuroimaging findings in patients with COVID‐19: a retrospective multicenter study publication-title: Neurology – volume: 35 start-page: 621 issue: 9 year: 2020 end-page: 627 article-title: Neurological complications in critical patients with COVID‐19 publication-title: Neurología (English Edition) – volume: 87 start-page: 155 year: 2020 end-page: 158 article-title: Plasmapheresis treatment in COVID‐19–related autoimmune meningoencephalitis: case series publication-title: Brain Behav Immun – volume: 95 start-page: e1060 issue: 8 year: 2020 end-page: e1070 article-title: Neurologic manifestations in hospitalized patients with COVID‐19: The ALBACOVID registry publication-title: Neurology – start-page: 1 year: 2020 end-page: 8 article-title: Neurologic manifestations in 1760 COVID‐19 patients admitted to Papa Giovanni XXIII Hospital, Bergamo, Italy publication-title: J Neurol – volume: 20 start-page: 773 issue: 7 year: 2020 article-title: Real estimates of mortality following COVID‐19 infection publication-title: Lancet Infect Dis – volume: 6 start-page: 118 year: 2019 article-title: Infections in the elderly critically‐ill patients publication-title: Front Med – volume: 6 issue: 7 year: 2009 article-title: Preferred reporting items for systematic reviews and meta‐analyses: the PRISMA statement publication-title: PLoS Med – volume: 8 start-page: 2 issue: 1 year: 2015 end-page: 10 article-title: The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta‐analysis, and clinical practice guideline: a systematic review publication-title: J Evid Based Med – volume: 21 start-page: 100275 year: 2020 article-title: Encephalopathy in COVID‐19 patients; viral, parainfectious, or both? publication-title: Eneurologicalsci – volume: 76 start-page: 233 year: 2020 end-page: 235 article-title: Guillain Barre syndrome associated with COVID‐19 infection: a case report publication-title: J Clin Neurosci – volume: 45 start-page: 156 year: 2020 end-page: 161 article-title: Intensive care for seriously ill patients affected by novel coronavirus sars‐CoV–2: experience of the Crema Hospital, Italy publication-title: Am J Emerg Med – volume: 27 start-page: 2322 issue: 11 year: 2020 end-page: 2328 article-title: Assessment of neurological manifestations in hospitalized patients with COVID‐19 publication-title: Eur J Neurol – volume: 27 start-page: 12 year: 2020 end-page: 25 article-title: Meningoencephalitis associated with COVID‐19: a systematic review publication-title: J Neuro Virol – volume: 268 start-page: 751 issue: 3 year: 2021 end-page: 757 article-title: Immune‐mediated neurological syndromes in SARS‐CoV‐2‐infected patients publication-title: J Neurol – volume: 93 start-page: 206 issue: 1 year: 2021 end-page: 222 article-title: Encephalopathy in patients with COVID‐19: a review publication-title: J Med Virol – volume: 143 start-page: 3104 issue: 10 year: 2020 end-page: 3120 article-title: The emerging spectrum of COVID‐19 neurology: clinical, radiological and laboratory findings publication-title: Brain – volume: 71 start-page: 1050 issue: 10 year: 2016 end-page: 1058 article-title: Neuroimaging in encephalitis: analysis of imaging findings and interobserver agreement publication-title: Clin Radiol – volume: 418 start-page: 117118 year: 2020 article-title: Neurology of COVID‐19 in Singapore publication-title: J Neurol Sci – volume: 92 start-page: 218 issue: 2 year: 2020 end-page: 220 article-title: COVID‐19 impact on consecutive neurological patients admitted to the emergency department publication-title: J Neurol Neurosurg Psychiatry – volume: 36 start-page: 220 issue: 2 year: 2019 end-page: 228 article-title: Extracorporeal membrane oxygenation in pregnant and postpartum women: a systematic review and meta‐regression analysis publication-title: J Intensive Care Med – year: 2020 article-title: The clinical spectrum of encephalitis in COVID‐19 disease: the ENCOVID multicentre study publication-title: Medrxiv – volume: 13 issue: 12 year: 2020 article-title: Acute disseminated encephalomyelitis (ADEM) associated with COVID‐19 publication-title: BMJ Case Rep CP – volume: 21 start-page: e925641 year: 2020 end-page: 925641 article-title: SARS‐CoV‐2‐associated acute hemorrhagic, necrotizing encephalitis (AHNE) presenting with cognitive impairment in a 44‐year‐old woman without comorbidities: a case report publication-title: Am J Case Rep – year: 2020 – volume: 148 start-page: e189 year: 2020 article-title: Frequency of five unusual presentations in patients with COVID‐19: results of the UMC‐19‐S1 publication-title: Epidemiol Infect – volume: 16 start-page: 636 issue: 11 year: 2020 end-page: 644 article-title: Lifting the mask on neurological manifestations of COVID‐19 publication-title: Nat Rev Neurol – volume: 93 start-page: 550 issue: 1 year: 2021 end-page: 558 article-title: Encephalitic syndrome and anosmia in COVID‐19: do these clinical presentations really reflect SARS‐CoV‐2 neurotropism? A theory based on the review of 25 COVID‐19 cases publication-title: J Med Virol – volume: 30 start-page: 105549 issue: 3 year: 2021 article-title: Stroke as a neurological complication of COVID‐19: a systematic review and meta‐analysis of incidence, outcomes and predictors publication-title: J Stroke Cerebrovasc Dis – volume: 72 start-page: 39 issue: 1 year: 2014 article-title: Metaprop: a Stata command to perform meta‐analysis of binomial data publication-title: Arch Public Health – volume: 12 issue: 8 year: 2020 article-title: Frequency of neurological presentations of coronavirus disease in patients presenting to a tertiary care hospital during the 2019 coronavirus disease pandemic publication-title: Cureus – volume: 58 start-page: 321 issue: 5 year: 2009 end-page: 328 article-title: Post‐infectious encephalitis in adults: diagnosis and management publication-title: J Infect – volume: 7 start-page: 875 issue: 10 year: 2020 end-page: 882 article-title: Neurological and neuropsychiatric complications of COVID‐19 in 153 patients: a UK‐wide surveillance study publication-title: Lancet Psychiatry – volume: 41 start-page: 1804 issue: 10 year: 2020 end-page: 1808 article-title: Imaging features of acute encephalopathy in patients with COVID‐19: a case series publication-title: Am J Neuroradiol – volume: 24 start-page: 1 issue: 1 year: 2020 end-page: 11 article-title: Delirium and encephalopathy in severe COVID‐19: a cohort analysis of ICU patients publication-title: Crit Care – year: 2019 – volume: 21 start-page: 5475 issue: 15 year: 2020 article-title: SARS‐CoV‐2 and the nervous system: from clinical features to molecular mechanisms publication-title: Int J Mol Sci – year: 2013 – volume: 8 start-page: 100136 year: 2020 article-title: Acute encephalopathy is associated with worse outcomes in COVID‐19 patients publication-title: Brain Behav Immun Health – ident: e_1_2_12_13_1 doi: 10.1002/jmv.26309 – ident: e_1_2_12_34_1 doi: 10.3389/fneur.2020.00805 – ident: e_1_2_12_45_1 doi: 10.1016/j.crad.2016.03.015 – ident: e_1_2_12_7_1 doi: 10.1016/j.nrleng.2020.07.012 – ident: e_1_2_12_30_1 doi: 10.1017/S0950268820001910 – ident: e_1_2_12_41_1 doi: 10.3389/fmed.2019.00118 – ident: e_1_2_12_11_1 doi: 10.1002/jmv.26207 – ident: e_1_2_12_19_1 doi: 10.1186/2049-3258-72-39 – ident: e_1_2_12_32_1 doi: 10.1136/jnnp-2020-323929 – ident: e_1_2_12_37_1 doi: 10.1016/j.bbih.2020.100136 – volume-title: A Language and Environment for Statistical Computing year: 2013 ident: e_1_2_12_21_1 – ident: e_1_2_12_20_1 doi: 10.1002/9781119536604 – ident: e_1_2_12_18_1 doi: 10.1111/jebm.12141 – ident: e_1_2_12_39_1 doi: 10.1016/S2215-0366(20)30287-X – ident: e_1_2_12_38_1 doi: 10.1016/j.ensci.2020.100275 – ident: e_1_2_12_3_1 doi: 10.1016/j.jstrokecerebrovasdis.2020.105549 – ident: e_1_2_12_27_1 doi: 10.1212/WNL.0000000000010112 – ident: e_1_2_12_9_1 doi: 10.1016/j.ajem.2020.08.005 – ident: e_1_2_12_15_1 doi: 10.1371/journal.pmed.1000097 – ident: e_1_2_12_10_1 doi: 10.1016/j.bbi.2020.05.022 – ident: e_1_2_12_26_1 doi: 10.1016/j.jns.2020.117118 – ident: e_1_2_12_8_1 doi: 10.1007/s00415-020-10108-x – ident: e_1_2_12_5_1 doi: 10.1016/j.jocn.2020.04.062 – ident: e_1_2_12_48_1 doi: 10.1038/s41582-020-0398-3 – ident: e_1_2_12_49_1 doi: 10.12659/AJCR.925641 – volume: 27 start-page: 12 year: 2020 ident: e_1_2_12_12_1 article-title: Meningoencephalitis associated with COVID‐19: a systematic review publication-title: J Neuro Virol – ident: e_1_2_12_50_1 doi: 10.1186/s41983-020-00244-6 – ident: e_1_2_12_44_1 doi: 10.1016/j.jinf.2009.02.011 – ident: e_1_2_12_36_1 doi: 10.1212/WNL.0000000000009937 – ident: e_1_2_12_16_1 – ident: e_1_2_12_28_1 doi: 10.1002/acn3.51210 – start-page: 1 year: 2020 ident: e_1_2_12_35_1 article-title: Neurologic manifestations in 1760 COVID‐19 patients admitted to Papa Giovanni XXIII Hospital, Bergamo, Italy publication-title: J Neurol – ident: e_1_2_12_4_1 doi: 10.3201/eid2609.202122 – ident: e_1_2_12_31_1 doi: 10.1093/brain/awaa240 – ident: e_1_2_12_23_1 doi: 10.1186/s13054-020-03200-1 – volume: 12 start-page: e10784 issue: 10 year: 2020 ident: e_1_2_12_46_1 article-title: COVID‐19 and the brain: acute encephalitis as a clinical manifestation publication-title: Cureus – ident: e_1_2_12_14_1 doi: 10.21203/rs.3.rs-65579/v1 – ident: e_1_2_12_6_1 doi: 10.1136/bcr-2020-238668 – ident: e_1_2_12_47_1 doi: 10.3390/ijms21155475 – ident: e_1_2_12_22_1 – ident: e_1_2_12_29_1 doi: 10.1111/ene.14444 – ident: e_1_2_12_40_1 doi: 10.1016/S1473-3099(20)30195-X – ident: e_1_2_12_42_1 doi: 10.1136/bcr-2020-239597 – ident: e_1_2_12_17_1 doi: 10.1177/0885066619892826 – ident: e_1_2_12_25_1 doi: 10.3174/ajnr.A6715 – year: 2020 ident: e_1_2_12_43_1 article-title: COVID‐19‐associated acute disseminated encephalomyelitis: a case report publication-title: MedRxiv – year: 2020 ident: e_1_2_12_33_1 article-title: The clinical spectrum of encephalitis in COVID‐19 disease: the ENCOVID multicentre study publication-title: Medrxiv – ident: e_1_2_12_2_1 doi: 10.1016/j.bbih.2020.100094 – volume: 12 issue: 8 year: 2020 ident: e_1_2_12_24_1 article-title: Frequency of neurological presentations of coronavirus disease in patients presenting to a tertiary care hospital during the 2019 coronavirus disease pandemic publication-title: Cureus |
| SSID | ssj0002720 |
| Score | 2.640646 |
| SecondaryResourceType | review_article |
| Snippet | Background and purpose
Although COVID‐19 predominantly affects the respiratory system, recent studies have reported the occurrence of neurological disorders... Although COVID-19 predominantly affects the respiratory system, recent studies have reported the occurrence of neurological disorders such as stroke in... Background and purposeAlthough COVID‐19 predominantly affects the respiratory system, recent studies have reported the occurrence of neurological disorders... |
| SourceID | pubmedcentral proquest pubmed crossref wiley |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 3491 |
| SubjectTerms | Cerebrospinal fluid complication Confidence intervals coronavirus COVID-19 Encephalitis Encephalitis - epidemiology Encephalitis - etiology Humans Incidence Infections Infectious Diseases Inflammation Meta-analysis Morbidity Mortality Nervous System Diseases Neurological diseases Patients Pleocytosis Respiratory system Review SARS-CoV-2 Systematic review |
| Title | Encephalitis as a neurological complication of COVID‐19: A systematic review and meta‐analysis of incidence, outcomes, and predictors |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fene.14913 https://www.ncbi.nlm.nih.gov/pubmed/33982853 https://www.proquest.com/docview/2572520221 https://www.proquest.com/docview/2526307675 https://pubmed.ncbi.nlm.nih.gov/PMC8239820 |
| Volume | 28 |
| WOSCitedRecordID | wos000656820000001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVWIB databaseName: Wiley Online Library Free Content customDbUrl: eissn: 1468-1331 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0002720 issn: 1351-5101 databaseCode: WIN dateStart: 19970101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell – providerCode: PRVWIB databaseName: Wiley Online Library Full Collection 2020 customDbUrl: eissn: 1468-1331 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0002720 issn: 1351-5101 databaseCode: DRFUL dateStart: 19970101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB6VghAXyptty8pFHDg00iZOnLg9Ve2uqEQXhCjsLfJTrQTZah-cuXLrb-wv6YyTDbtqkSoh5RAp48SxZ8af7fE3AO8S6mctRSTQQ0aptirShc0jBK9cChvHPrMh2UQ-HBajkfy8BvuLszA1P0S74EaWEfw1GbjS0yUjR1eAZi5Dxto4jSl7wffjYeuFaX8xTLayOKL6NKxCFMXTllwdi24AzJtxksv4NQxAg43_qvoTeNzgTnZQK8pTWHPVM3h40uysP4c_fTq-eEao_HzKFF4sUF02rpEth56zsWeHn74dH139vozlHjtgf_mgWX0WhqnKsp9uplBENbwnVIxW9kMW0102ns_wpW66G2QvJlQVSv3zAk4H_a-HH6ImTUNkMp7zCBEPz7jVMQ63oki0Rgji0P8a1A8Ed6LoWWN94VUqrZLEB6hUz5lUe63yghv-EtarceVeA1PeKGLsy3rap8466Y1wVqXci8TrTHTg_aLDStNwmFMqjR_lYi6DTVuGpu3A21b0oibuuE1oe9HrZWO70xKdWJIliG3iDuy0j9HqaCtFVW48J5lEoHfE2VYHXtVK0n6Fc0m0gPjyfEV9WgFi9F59Up2fBWbvgtgYkx7-ZlCff1e87A_74Wbz7qJb8CihgJwQibgN67PJ3L2BB-YX6tWkC_fyUdGF-0dfBqcfu8GWrgFCRiP1 |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB5VpQIutDy7fYBBHDg00iZOnBhxqdqtuqINHAr0FvmpVqLZah-cufbGb-SXMONkw64KEhJSDpE8cZx4ZvzZHn8D8DqhftZSRAI9ZJRqqyJd2DxC8MqlsHHsMxuSTeRlWZyfy48r8G5-Fqbhh-gW3Mgygr8mA6cF6QUrR1-Adi4pZe2dFIEGJW74Miw7P0w7jGG6lcURtajlFaI4nu7R5dHoFsS8HSm5iGDDEHS0_n-N34AHLfRk-42uPIQVVz-Cu6ft5vpjuBnQCcYLAuaXE6bwYoHtsvWObDH6nI08O_jweXj48_uPWL5l--w3JTRrjsMwVVt25aYKRVRLfUKP0eJ-SGS6x0azKVbqJntB9npMTaHsP0_g09Hg7OA4ajM1RCbjOY8Q9PCMWx3jiCuKRGtEIQ5dsEEVQXwnir411hdepdIqSZSASvWdSbXXKi-44U9htR7VbhOY8kYRaV_W1z511klvhLMq5V4kXmeiB2_mPVaZlsacsml8rebTGfy1Vfi1PXjViV433B1_EtqZd3vVmu-kQj-WZAnCm7gHL7tiNDzaTVG1G81IJhHoIHHC1YNnjZZ0b-FcEjMgVp4v6U8nQKTeyyX15UUg9y6IkDHp42cG_fl7w6tBOQg3W_8u-gLuHZ-dnlQnw_L9NtxPKD4nBCbuwOp0PHO7sGa-oY6NnwdT-gVOOCWL |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB5VW1RxKZRHWSjFIA4cGmkTJ05Scam6u6KiLBWiqLfIT7USza72wZkrN34jv6QzjjfsqiAhIeUQKePEsWfGn-3xNwCvE-pnVYpIoIeMUmVkpAqTRwheeSlMHLvM-GQT-WhUXFyUZxvwdnkWpuGHaBfcyDK8vyYDtxPjVqwcfQHaeUkpazdTSiLTgc3-p-H5aeuJaY_RT7iyOKI6BWYhiuRpC6-PR7dA5u1YyVUM6weh4b3_q_592A7gkx012rIDG7Z-AFsfwvb6Q_gxoDOMlwTNr2ZM4sU832Xwj2w1_pyNHTv--OWk_-v7z7g8ZEfsNyk0aw7EMFkbdm3nEkVkID-hYrS871OZHrDxYo4vtbMDLzuZUlUo_88jOB8OPh-_i0KuhkhnPOcRwh6ecaNiHHNFkSiFOMSiE9aoJIjwRNEz2rjCybQ0siRSQCl7VqfKKZkXXPPH0KnHtX0CTDotibYv6ymXWmNLp4U1MuVOJE5logtvlj1W6UBkTvk0vlbLCQ02beWbtguvWtFJw97xJ6G9ZbdXwYBnFXqyJEsQ4MRdeNk-RtOj_RRZ2_GCZBKBLhKnXF3YbbSk_QrnJXED4svzNf1pBYjWe_1JfXXp6b0LomRMevibXn_-XvFqMBr4m6f_LvoCts76w-r0ZPT-GdxNKEDHRybuQWc-XdjncEd_QxWb7gdbugE7VCY0 |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Encephalitis+as+a+neurological+complication+of+COVID%E2%80%9019%3A+A+systematic+review+and+meta%E2%80%90analysis+of+incidence%2C+outcomes%2C+and+predictors&rft.jtitle=European+journal+of+neurology&rft.au=Siow%2C+Isabel&rft.au=Lee%2C+Keng+Siang&rft.au=Zhang%2C+John+J.+Y.&rft.au=Saffari%2C+Seyed+Ehsan&rft.date=2021-10-01&rft.pub=John+Wiley+and+Sons+Inc&rft.issn=1351-5101&rft.eissn=1468-1331&rft.volume=28&rft.issue=10&rft.spage=3491&rft.epage=3502&rft_id=info:doi/10.1111%2Fene.14913&rft_id=info%3Apmid%2F33982853&rft.externalDocID=PMC8239820 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1351-5101&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1351-5101&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1351-5101&client=summon |